Citations

Clear

1053 citation(s) found for "Andre, F".

Mitochondria in Control of Cell Fate
Folmes, Clifford D.L. , Dzeja, Petras P. , Nelson, Timothy J. , Terzic, André , Nelson, Timothy J , Folmes, Clifford D L

Mayo Clinic

Circulation Research | February 15, 2012 | Volume: 110 | Issue: 4 | Pages: 526-529

10.1161/res.0b013e31824ae5c1 | PMID 22343555 Get It

Dynamic phosphometabolomic profiling of human tissues and transgenic models by18O-assisted31P NMR and mass spectrometry
Nemutlu, Emirhan , Gupta, Anu, Juranić, Nenad, Dzeja, Petras P. , Zhang, Song , Macura, Slobodan , Terzic, André , Jahangir, Arshad

Mayo Clinic

Physiological Genomics | January 11, 2012 | Volume: 44 | Issue: 7 | Pages: 386-402

10.1152/physiolgenomics.00152.2011 | PMID 22234996 Get It

Next-generation screening of disease-related metabolomic phenotypes requires monitoring of both metabolite levels and turnover rates. Stable isotope18O-assisted31P nuclear magnetic resonance (NMR) and mass spectrometry uniquely allows simultaneous measurement of phosphometabolite levels and turnover rates in tissue and blood samples. The18O labeling procedure is based on the incorporation of one18O into Pifrom [18O]H2O with each act of ATP hydrolysis and the distribution of18O-labeled phosphoryls among phosphate-carrying molecules. This enables simultaneous recording of ATP synthesis and utilization, phosphotransfer fluxes through adenylate kinase, creatine kinase, and glycolytic pathways, as well as mitochondrial substrate shuttle, urea and Krebs cycle activity, glycogen turnover, and intracellular energetic communication. Application of expanded18O-labeling procedures has revealed significant differences in the dynamics of G-6-P[18O] (glycolysis), G-3-P[18O] (substrate shuttle), and G-1-P[18O] (glycogenolysis) between human and rat atrial myocardium. In human atria, the turnover of G-3-P[18O], which defects are associated with the sudden death syndrome, was significantly higher indicating a greater importance of substrate shuttling to mitochondria. Phosphometabolomic profiling of transgenic hearts deficient in adenylate kinase (AK1−/−), which altered levels and mutations are associated to human diseases, revealed a stress-induced shift in metabolomic profile with increased CrP[18O] and decreased G-1-P[18O] metabolic dynamics. The metabolomic profile of creatine kinase M-CK/ScCKmit−/−-deficient hearts is characterized by a higher G-6-[18O]P turnover rate, G-6-P levels, glycolytic capacity, γ/β-phosphoryl of GTP[18O] turnover, as well as β-[18O]ATP and β-[18O]ADP turnover, indicating altered glycolytic, guanine nucleotide, and adenylate kinase metabolic flux. Thus,18O-assisted gas chromatography-mass spectrometry and31P NMR provide a suitable platform for dynamic phosphometabolomic profiling of the cellular energetic system enabling prediction and diagnosis of metabolic diseases states.
Patient-Centric Clinical Pharmacology Advances the Path to Personalized Medicine
Waldman, Scott A. , Terzic, André , Waldman, Scott A

Mayo Clinic

Biomarkers in Medicine | November 21, 2011 | Volume: 5 | Issue: 6 | Pages: 697-700

10.2217/bmm.11.78 | PMID 22103605 Get It

Energy Metabolism in Nuclear Reprogramming
Folmes, Clifford D.L. , Nelson, Timothy J. , Terzic, André , Nelson, Timothy J , Folmes, Clifford D L

Mayo Clinic

Biomarkers in Medicine | November 21, 2011 | Volume: 5 | Issue: 6 | Pages: 715-729

10.2217/bmm.11.87 | PMID 22103608 Get It

Heart Failure Transcriptome
Hall, Jennifer L. , Terzic, André

Mayo Clinic

Circulation: Cardiovascular Genetics | October 18, 2011 | Volume: 4 | Issue: 5 | Pages: 469-471

10.1161/circgenetics.111.961367 | PMID 22010160 Get It

Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma
Tanas, Munir R. , Oliveira, André M. , Erickson‐Johnson, Michele R., Hespelt, Jessica, Hanwright, Philip J. , Flanagan, John J., Fenwick, Kerry, Natrajan, Rachael , Mitsopoulos, Costas , Zvelebil, Marketa , Hoch, Benjamin , Sciot, Raf , West, Robert B. , Lazar, Alexander J. , Ashworth, Alan , Lord, Christopher J. , Rubin, Mark A. , Sboner, Andrea , Luo, Yuling , Weiss, Sharon Whelan , Dêbiec‐Rychter, Maria , Reis‐Filho, Jorge S. , Gerstein, Mark , Rubin, Brian P. , Lazar, Alexander J , Sciot, Raf , Rubin, Mark A

Mayo Clinic

Science Translational Medicine | September 1, 2011 | Volume: 3 | Issue: 98 | Pages: No page available

10.1126/scitranslmed.3002409 | PMID 21885404 Get It

A newly identified gene fusion defines the vascular cancer epithelioid hemangioendothelioma and encodes a chimeric transcription factor.
Critical role for Syk in responses to vascular injury
André, Patrick, Morooka, Toshifumi, Sim, Derek , Abe, Keith , Lowell, Clifford A. , Nanda, Nisha, Delaney, Suzanne M., Siu, Gail, Yan, Yibing, Hollenbach, Stan, Gao, Huiyun, Wang, Yunmei, Nakajima, Kohsuke, Parikh, Sahil A. , Shi, Can , Owen, Whyte G., Sinha, Uma, Simon, Daniel I. , Pandey, Anjali , Phillips, David R.

Mayo Clinic

Blood | September 1, 2011 | Volume: 118 | Issue: 18 | Pages: 5000-5010

10.1182/blood-2011-06-360743 | PMID 21881044 Get It

AbstractAlthough current antiplatelet therapies provide potent antithrombotic effects, their efficacy is limited by a heightened risk of bleeding and failure to affect vascular remodeling after injury. New lines of research suggest that thrombosis and hemorrhage may be uncoupled at the interface of pathways controlling thrombosis and inflammation. Here, as one remarkable example, studies using a novel and highly selective pharmacologic inhibitor of the spleen tyrosine kinase Syk [PRT060318; 2-((1R,2S)-2-aminocyclohexylamino)-4-(m-tolylamino)pyrimidine-5-carboxamide] coupled with genetic experiments, demonstrate that Syk inhibition ameliorates both the acute and chronic responses to vascular injury without affecting hemostasis. Specifically, lack of Syk (murine radiation chimeras) attenuated shear-induced thrombus formation ex vivo, and PRT060318 strongly inhibited arterial thrombosis in vivo in multiple animal species while having minimal impact on bleeding. Furthermore, leukocyte-platelet–dependent responses to vascular injury, including inflammatory cell recruitment and neointima formation, were markedly inhibited by PRT060318. Thus, Syk controls acute and long-term responses to arterial vascular injury. The therapeutic potential of Syk may be exemplary of a new class of antiatherothrombotic agents that target the interface between thrombosis and inflammation.
Intrathecal administration ofNTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain
Guillemette, Annie, Dansereau, Marc‐André, Beaudet, Nicolas , Richelson, Elliott, Sarret, Philippe

Mayo Clinic

European Journal of Pain | August 21, 2011 | Volume: 16 | Issue: 4 | Pages: 473-484

10.1016/j.ejpain.2011.07.008 | PMID 22396077 Get It

AbstractChronic neuropathic pain arising from peripheral nerve damage is a severe clinical issue where there is a major unmet medical need. We previously demonstrated that both neurotensin (NT) receptor subtypes 1 (NTS1) and 2 (NTS2) are involved in mediating the naloxone‐insensitive antinociceptive effects of neurotensin in different analgesic tests including hotplate, tail‐flick, and tonic pain. However, the role of these receptors in neuropathic pain management has been poorly investigated. In the present study, we therefore examined whether intrathecal delivery ofNTS1 agonists was effective in reducing neuropathic pain symptoms in rats. Neuropathy was induced by sciatic nerve constriction (CCImodel), and the development of mechanical allodynia and thermal hyperalgesia on the ipsi‐ and contralateral hind paws was examined 3, 7, 14, 21, and 28 days post‐surgery.CCI‐operated rats exhibited significant increases in thermal and mechanical hypersensitivities over a 28‐day testing period. Spinal injection ofNTtoCCIrats alleviated the behavioral responses to radiant heat and mechanical stimuli, with a maximal reversal of 91% of allodynia at 6 μg/kg. Intrathecal administration of theNTS1‐selective agonist,PD149163 (30–90 μg/kg) also produced potent anti‐allodynic and anti‐hyperalgesic effects in nerve‐injured rats. Likewise, heat hyperalgesia and tactile allodynia produced byCCIof the sciatic nerve were fully reversed by theNTS1 agonist,NT69L(5–25 μg/kg). Altogether, these results support the idea that theNTS1 receptor subtype is involved in pain modulation, and the potential use ofNTS1 agonists for the treatment of painful neuropathies.
Advances in Cardiac ATP-Sensitive K + Channelopathies From Molecules to Populations
Alekseev, Alexey E., Reyes, Santiago , Olson, Timothy M. , Terzic, André , Yamada, Satsuki , Olson, Timothy M

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | August 16, 2011 | Volume: 4 | Issue: 4 | Pages: 577-585

10.1161/circep.110.957662 | PMID 21846889 Get It

Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistula
Lu, Kang , Hernandez, Melissa C., Croatt, Anthony J., Grande, Joseph P. , Juncos, Julio P., Vercellotti, Gregory M. , Hebbel, Robert P. , Katušić, Zvonimir S. , Nath, Karl A. , Yamada, Satsuki , Terzic, André

Mayo Clinic

American Journal of Physiology-Renal Physiology | June 23, 2011 | Volume: 301 | Issue: 4 | Pages: F845-F851

10.1152/ajprenal.00311.2011 | PMID 21697243 Get It

The study of hemodynamic alterations following the creation of an arteriovenous fistula (AVF) is relevant to vascular adaptive responses and hemodialysis access dysfunction. This study examined such alterations in a murine AVF created by anastomosing the carotid artery to the jugular vein. AVF blood flow was markedly increased due to reduced AVF vascular resistance. Despite such markedly increased basal blood flow, AVF blood flow further increased in response to acetylcholine. This AVF model exhibited increased cardiac output and decreased systemic vascular resistance; the kidney, in contrast, exhibited decreased blood flow and increased vascular resistance. Augmentation in AVF blood flow was attended by increased arterial heme oxygenase-1 (HO-1) mRNA and protein expression, the latter localized to smooth muscle cells of the AVF artery; AVF blood flow was substantially reduced in HO-1−/− mice compared with HO-1+/+ mice. Finally, in a murine model of a representative disease known to exhibit impaired hemodynamic responses (sickle cell disease), the creation of an AVF was attended by decreased AVF flow and impaired AVF function. We conclude that this AVF model exhibits markedly increased AVF blood flow, a vasodilatory reserve capacity, increased cardiac output, decreased renal blood flow, and a dependency on intact hemodynamic responses, in general, and HO-1 expression, in particular, in achieving and maintaining AVF blood flow. We suggest that these findings support the utility of this model in investigating the basis for and the consequences of hemodynamic stress, including shear stress, and the pathobiology of hemodialysis AVF dysfunction.